← 返回专利悬崖列表

CAS 4746-97-8

1,4 Cyclohexanedione ethylene ketal1,4-dioxaspiro[4.5]decan-8-one1,4-Dioxaspiro[4.5]decan-8-one

登记编号:(I)1024528-1-a,(I)1024528-1-d、(XI)1024528-3-b、CEBR-001、DEXP-001

应用背景(按来源药适应症)

非小细胞肺癌普拉替尼甲状腺瘤普拉替尼甲状腺髓样癌普拉替尼疼痛Cebranopadol hemicitrate急性疼痛Cebranopadol hemicitrate神经痛Cebranopadol hemicitrate腰痛Cebranopadol hemicitrate物质相关性障碍Cebranopadol hemicitrate慢性疼痛Cebranopadol hemicitrate肺嗜酸粒细胞增多盐酸右旋普拉克索哮喘盐酸右旋普拉克索慢性阻塞性肺疾病盐酸右旋普拉克索高嗜酸性粒细胞综合征盐酸右旋普拉克索肌萎缩性侧索硬化盐酸右旋普拉克索嗜酸粒细胞性哮喘盐酸右旋普拉克索

来源药(使用该中间体的合成路线)

品种梯队到期年
普拉替尼PralsetinibTier C · 观察 / 贸易2031
Cebranopadol hemicitrateTier C · 观察 / 贸易-
盐酸右旋普拉克索Dexpramipexole DihydrochlorideTier C · 观察 / 贸易-
氢溴酸依他佐辛Eptazocine hydrobromideTier C · 观察 / 贸易-

合成路线中的位置(上下游链)

按路线登记顺序排列,左→右为合成方向;高亮为当前 CAS,其余可点击跳转对应档案。

普拉替尼优化路线步数:6总收率:/
1,4 Cyclohexanedione ethylene ketal→Methyl 1-methoxy-4-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)cyclohexane-1-carboxylate→1,4-Dioxaspiro[4.5]decane-8-carbonitrile→N-Hydroxy-1,4-dioxaspiro[4.5]decane-8-carboximidamide→1,4-Dioxaspiro[4.5]decane-8-carboximidamide→1-Ethoxybutane-1,3-dione→2-(1,4-Dioxaspiro[4.5]decan-8-yl)-6-methylpyrimidin-4-ol→4-(4-Hydroxy-6-methylpyrimidin-2-yl)cyclohexan-1-one
Cebranopadol hemicitrate原研路线步数:6总收率:640mg
1,4-dioxaspiro[4.5]decan-8-one→N-methyl-1,4-dioxaspiro[4.5]decan-8-imine→4-(methylamino)-4-phenylcyclohexan-1-one→4-(dimethylamino)-4-phenylcyclohexan-1-one→2-(5-fluoro-1H-indol-3-yl)ethan-1-ol→(1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4-b]indol]-4-amine→(4-fluorophenyl)hydrazine hydrochloride→2,3-dihydrofuran

本站可供应的对应中间体

目录暂未收录该靶点的在售中间体 —— 可直接发起询价,需求会进入撮合池。

本页为中间体 CAS 注册档案:同 CAS 的多条路线登记已合并;后续供应商报价与买方需求以该 CAS 为主键撮合。